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Surveillance of noroviruses in Italy identified the 
novel GII.17 human norovirus strain, Kawasaki 2014, 
in February 2015. This novel strain emerged as a 
major cause of gastroenteritis in Asia during 2014/15, 
replacing the pandemic GII.4 norovirus strain Sydney 
2012, but being reported only sporadically elsewhere. 
This novel strain is undergoing fast diversification and 
continuous monitoring is important to understand the 
evolution of noroviruses and to implement the future 
strategies on norovirus vaccines.
During the winter season 2014/15, a novel GII.P17-
GII.17 norovirus (NoV) strain emerged in Asian coun-
tries [1-4]. Since its emergence, this novel NoV strain, 
named Kawasaki 2014, has replaced the previously 
dominant GII.4 genotype Sydney 2012 variant in Asia, 
and it has been detected in a limited number of cases 
on other continents [1-5]. This epidemiological trend is 
also reflected in the GenBank database, with the vast 
majority of the Kawasaki 2014 GII.17 NoV sequences 
generated in studies from the Asian continent.
Here we report the detection of the Kawasaki 2014 
GII.17 strain during the 2014/15 winter season in Italy. 
As sequence information on Kawasaki 2014 GII.17 
NoVs detected outside the Asian continent is limited 
[5], we determined the sequence of a large portion of 
the genome, including the full-length capsid gene of 
the GII.17 Kawasaki NoV strain circulating in Italy, and 
analysed the virus sequence with similar GII.17 NoV 
sequences available in the GenBank database.
Genotyping
The NoV genome contains three open reading frames 
(ORFs). ORF1 encodes non-structural proteins includ-
ing the RNA-dependent RNA polymerase (RdRp), while 
ORF2 and ORF3 encode the major capsid protein VP1 
and a minor structural protein VP2, respectively [6]. 
NoVs are classified in at least six genogroups, GI to 
GVI [6]. NoV genogroups are further divided in various 
genotypes based on differences in the RdRp region 
(polymerase genotype, or pol type) and in the VP1 
(capsid genotype, or cap type) [7]. NoV genotyping was 
performed using standardised sequence analysis web-
based tools developed and maintained by the NoroNet 
[8].
Surveillance of noroviruses in Italy
The Italian Study Group for Enteric Viruses (ISGEV; 
http://isgev.net) monitors the epidemiology of enteric 
viruses in children through hospital-based surveillance. 
A subset of about half of the NoV-positive samples is 
systematically genotyped in both region A (ORF1, RdRp) 
and region C (ORF2, capsid). From September 2014 to 
March 2015, NoV prevalence was 12% (137/1,144) and 
NoVs were typed in 81 cases (59%). GII.P17-GII.17 NoV 
strains were detected in two sporadic cases of acute 
severe gastroenteritis in young children hospitalised in 
February 2015 in two distinct Italian regions.
Sequence analysis
Upon direct sequencing of the RT-PCR amplicons, the 
two strains, PR668/2015/ITA and BA603–6/2015/
ITA, were found to be identical in the short diagnos-
tic regions A and C. We determined the sequence of a 
large portion (3.2 kb) of the genome at the 3’ end for 
strain PR668/2015/ITA. Viral RNA was extracted from 
140 µl of stool suspension using the QIAmp viral RNA 
kit (Qiagen, GmbH, Hilden, Germany). A 3’-rapid ampli-
fication of cDNA ends (RACE)-PCR) protocol was used 
to generate the 3.2-kb amplicon encompassing the 3’ 
end of ORF1, the full-length ORF2 and ORF3, and the 3’ 
untranslated region (UTR) until the poly(A) tail, using 
the reverse primer VN3T20 [9] and the forward primer 
JV12Y [10]. The RACE product was cloned and the 
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Figure 1
Phylogenetic analysis based on partial ORF1, full ORF2 and full ORF3 sequences of GII.17 NoV, Italy, February 2015
ORF1 
ORF2 
ORF3 
 LC043139| Norovirus Hu/GII.17/Nagano7-1/2013/JPN
 LC043305| Norovirus Hu/GII.17/Nagano8-1/2014/JPN
 LC043168| Norovirus Hu/GII.17/Saitama5309/2013/JPN
 AB983218| Norovirus Hu/GII.17/Kawasaki323/2014/JPN
 LC043167| Norovirus Hu/GII.17/Saitama5203/2013/JPN
 KJ156329| Norovirus Hu/GII.17/13-BH-1/2013/TWA
I
 KT346356| Norovirus Hu/GII.17/PR668/2015/ITA
 KR083017| Norovirus Hu/GII.17/Gaithersburg/2014/US
 KR020503| Norovirus Hu/GII.17/41621/Guangzhou/2014/CHN
 LC037415| Norovirus Hu/GII.17/Kawasaki308/2015/JPN
 KP998539| Norovirus Hu/GII.17/CUHK-NS-463/2014/HKG
II
GII.P17_GII.17
GII.P13_GII.17 JQ751044| Norovirus Hu/GII.17/Wuhan/Z776/2007/CHN
GII.P4_GII.17 KC597139| Norovirus Hu/GII.17/C142/1978/GUF
GII.P16_GII.17 KJ196286| Norovirus Hu/GII.17/GII/Hu/Saitama/T87/2002/JPN
100
96
99
100
0.02
 KJ156329| Norovirus Hu/GII.17/13-BH-1/2013/TWA
 LC043167| Norovirus Hu/GII.17/Saitama5203/2013/JPN
 LC043168| Norovirus Hu/GII.17/Saitama5309/2013/JPN
 AB983218| Norovirus Hu/GII.17/Kawasaki323/2014/JPN
 LC043139| Norovirus Hu/GII.17/Nagano7-1/2014/JPN
 LC043305| Norovirus Hu/GII.17/Nagano8-1/2014/JPN
I
 KR083017| Norovirus Hu/GII.17/Gaithersburg/2014/USA
 KT346356| Norovirus Hu/GII.17/PR668/2015/ITA
 KR020503| Norovirus Hu/GII.17/41621/Guangzhou/2014/CHN
 KP998539| Norovirus Hu/GII.17/CUHK-NS-463/2014/HKG
 LC037415| Norovirus Hu/GII.17/Kawasaki308/2015/JPN
II
GII.P17_GII.17
GII.P13_GII.17 DQ438972| Norovirus Hu/GII.17/Katrina-17/2005/USA
GII.P4_GII.17 KC597139| Norovirus Hu/GII.17/C142/1978/GUF
GII.P16_GII.17 KJ196286| Norovirus Hu/GII.17/Saitama/T87/2002/JPN100
99
99
94
10087
0.02
 KR020503| Norovirus Hu/GII.17/41621/Guangzhou/2014/CHN
 KP698929| Norovirus Hu/GII.17/CUHK-NS-494/2014/HKG
 LC037415| Norovirus Hu/GII.17/Kawasaki308/2015/JPN
 KP698931| Norovirus Hu/GII.17/CUHK-NS-513/2015/HKG
 KR858308| Norovirus Hu/GII.17/Shunyi-18/Beĳing/2015/CHN
 KP698930| Norovirus Hu/GII.17/CUHK-NS-511/2015/HKG
 KP998539| Norovirus Hu/GII.17/CUHK-NS-463/2014/HKG
 KP698928| Norovirus Hu/GII.17/UHK-NS-491/2014/HKG
 KR083017| Norovirus Hu/GII.17/Gaithersburg/2014/USA
 KT346356| Norovirus Hu/GII.17/PR668/2015/ITA
II
 LC043167| Norovirus Hu/GII.17/Saitama5203/2013/JPN
 KJ156329| Norovirus Hu/GII.17/13-BH-1/2013/TWA
 AB983218| Norovirus Hu/GII.17/Kawasaki323/2014/JPN
 LC043168| Norovirus Hu/GII.17/Saitama5309/2013/JPN
 LC043305| Norovirus Hu/GII.17/Nagano8-1/2014/JPN
 LC043139| Norovirus Hu/GII.17/Nagano7-1/2014/JPN
I
GII.P17_GII.17
GII.P13_GII.17 DQ438972| Norovirus Hu/GII.17/Katrina-17/2005/USA
GII.P4_GII.17 JN699043| Norovirus Hu/GII.17/C142/1978/GUF
 AY502009| Norovirus Hu/GII.17/CS-E1/2002/USA
 KJ196286| Norovirus Hu/GII.17/Saitama/T87/2002/JPN
GII.P16_GII.17
100
100
97
100
100
100
0.02
The Italian GII.P17_GII.17 strain is indicated in bold. Trees were built with the maximum-likelihood method, and bootstrapped with 1,000 
repetitions. Bootstrap values > 80% are indicated. The scale bar indicates the number of nucleotide substitutions per site.
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sequence was determined. Phylogenetic analysis was 
performed using MEGA v. 6.0 [11].
The 3.2-kb sequence of the Italian NoV GII.P17-GII.17 
strain has been deposited in GenBank under acces-
sion number KT346356. The partial sequence of ORF1 
(807 nt), and the full-length sequences of ORF2 (1,621 
nt) and ORF3 (849 nt) of strain PR668/2015/ITA were 
analysed with NoV GII.P17-GII.17 sequences available 
in the GenBank database (Figure 1).
The topology of the trees in the multi-target phyloge-
netic analysis was conserved, with the GII.P17-GII.17 
Kawasaki 2014 NoV forming a monophyletic branch 
and further segregating into two genetic subclades. 
The first subclade containing the Italian PR668/2015/
ITA strain clustered with GII.P17-GII.17 NoVs detected 
in China and Hong Kong during 2014 and 2015, and 
was genetically related (99.9%) to a GII.P17-GII.17 
strain detected in the United States (US) in November 
2014. The second subclade included GII.P17-GII.17 NoV 
detected in Japan and Taiwan during 2013 and 2014. 
The viruses of the two subclades showed a moder-
ate degree of nucleotide and amino acid divergence 
in the ORF2 and ORF3 sequences (1–1.9% nucleotide 
and 0–0.4% amino acid differences in ORF1, 0.4–4.1% 
nucleotides and 0.9–6.2% amino acids in ORF2, and 
0.5–3.3% nucleotides and 1–4.9% amino acids in 
ORF3). Interestingly, the GII.17 capsid sequences of 
the two genetic subclades differed markedly from the 
oldest GII.17 capsid sequence available in GenBank 
database, dating back to 1978 (23.3–24.8% nucleotide 
and 14.2–16.6% amino acid differences in ORF2, and 
19.4–27% nucleotide and 22.1–22.9% amino acid dif-
ferences in ORF3).
Several changes in the VP1 sequence were observed 
between the two Kawasaki 2014 subclades, mostly, 
but not exclusively, affecting the antibody blockade 
sites, i.e. the putative epitopes (A-E) located in the 
capsid protruding hypervariable P2 domain (Figure 
2). In the 543 amino acid VP1 protein, 17 amino acid 
changes (3.1% divergence) and four insertions sepa-
rate the two Kawasaki 2014 subclades, while 38 amino 
acid changes (7% divergence) and several insertions/
deletions separate the Kawasaki 2014 GII.17 NoV and 
the former GII.17 recombinant forms.
Discussion
NoVs are a major cause of acute gastroenteritis in both 
children and adults, with sporadic cases and outbreaks 
in various epidemiological settings [6]. Although more 
than 30 cap genotypes within genogroups GI, GII, and 
GIV may infect humans [7], a single genotype, GII.4, has 
been associated since the mid-1990s with the majority 
(ca 70–80%) of NoV-associated cases of gastroenteri-
tis worldwide [12]. GII.4 NoV strains undergo a continu-
ous process of genetic/antigenic diversification and 
periodically generate new strains via accumulation of 
point mutations or recombination, with one novel GII.4 
variant emerging every two to three years [12,13] and 
becoming predominant globally. NoV vaccines based 
on GII.4 NoV strains are currently under development 
[14].
In the winter season 2014/15, the GII.P17-GII.17 NoV 
strain Kawasaki 2014 emerged in Asia, replacing the 
previously dominant GII.4 genotype Sydney 2012 vari-
ant [1-4]. A signature of the Kawasaki 2014 variant is 
a novel pol type GII.P17, combined with a GII.17 ORF2 
gene. Previously, NoVs with a GII.17 cap genotype pos-
sessed a GII.P4, GII.P3, GII.P13 or GII.P16 pol genotype 
[15-18]. Although being predominant in several Asian 
countries, this novel GII.P17-GII.17 strain has been 
detected in a limited number of cases on other conti-
nents [1-5]. The epidemiological trends exhibited by 
the Kawasaki 2014 NoV variant are considered unique, 
as, so far, this is the only non-GII.4 NoV strain to have 
shown such epidemic pattern. The emergence of the 
novel GII.P17-GII.17 NoV strain in the Asian countries 
has been associated with increased NoV activity, i.e. 
with increased incidence of NoV-induced acute gastro-
enteritis, in the 2014/15 winter season, compared to 
the previous (2013/14) winter season [1-3]. This pattern 
has been observed, but not consistently, during the 
worldwide spread of NoV GII.4 variants [19]. Based on 
current literature on GII.17 NoVs, there is no indication 
on the clinical severity of the novel GII.17 virus [1-5]. 
Likewise, our study did not assess whether Kawasaki 
2014 NoVs are associated with increased severity of 
the clinical symptoms. 
Hospital-based surveillance for NoV identified the 
emergence of GII.P17-GII.17 strains in Italy at the end 
of the 2014/15 winter season, in February 2015. The 
viruses were genetically closely related to GII.17 NoVs 
identified in the US and Asia in 2014 and 2015 [3,5], 
forming a distinct subclade of the Kawasaki 2014 
GII.17 NoV variant. Co-circulation of two subclades 
of Kawasaki 2014 GII.17 NoV with several amino acid 
changes in the putative capsid epitopes could suggest 
that this novel strain is undergoing fast diversification, 
mirroring what was seen globally for the epidemic GII.4 
variants [12]. 
In addition, the emergence and spread of the novel 
GII.17 variant Kawasaki 2014 could represent a chal-
lenge for the efficacy of the candidate NoV vaccines 
[14], that target the globally predominant GII.4 NoV, as it 
is not known whether vaccine immunity elicited to GII.4 
NoV is cross-reactive with GII.17 viruses. Continuous 
monitoring of the epidemiology of human NoV is impor-
tant to understand the evolution of NoV and to imple-
ment the future strategies on NoV vaccines.
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